Position in PFE
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$335,916
-$109,039 QoQ
Shares Held
13,950
-12.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,047
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Relyea Zuckerberg Hanson LLC holds $22,750,410 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
34,711 | $8,815,552 | |
| 2 | ABBV |
AbbVie Inc.
|
27,498 | $6,919,596 | |
| 3 | LLY |
ELI LILLY & Co
|
3,409 | $4,088,857 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,095 | $1,297,207 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,176 | $401,255 | |
| 7 | PFE |
Pfizer Inc
This page
|
13,950 | $335,916 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,275 | $303,945 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,916 | 13,950 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $444,955 | 15,846 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $376,239 | 15,110 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $318,805 | 12,512 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $323,143 | 13,331 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $240,882 | 9,506 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $283,924 | 10,702 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $441,335 | 15,250 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $373,421 | 13,346 | Shares | Sole | 2024-10-31 | |
| 2024-03-31 | $309,190 | 11,142 | Shares | Sole | 2024-10-31 | |
| 2023-12-31 | $305,030 | 10,595 | Shares | Sole | 2024-10-31 | |
| 2023-09-30 | $461,560 | 13,915 | Shares | Sole | 2024-10-31 | |
| 2023-06-30 | $603,312 | 16,448 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $480,134 | 11,768 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $631,686 | 12,328 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $391,739 | 8,952 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $556,596 | 10,616 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $522,411 | 10,091 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $592,980 | 10,042 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $380,466 | 8,846 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $290,488 | 7,418 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $251,798 | 6,950 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $251,228 | 6,825 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $253,229 | 6,900 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $215,656 | 6,595 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $230,699 | 7,068 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||